Ceftaroline-Induced Thrombocytopenia: A Case Report

Abstract

Get full access to this article

View all access options for this article.

References

Arnold

Kukaswadia

Nazi

et al . A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia. J Thromb Haemost. 2013;11:169-176. doi:10.1111/jth.12052

Dellabella

Roshdy

Martin

KE.

High incidence of adverse effects with extended use of ceftaroline. Ann Pharmacother. 2016;50:1068-1069. doi:10.1177/1060028016667583

Jain

Chan

Rogers

Dellit

Lynch

Pottinger

PS.

High incidence of discontinuations due to adverse events in patients treated with ceftaroline. Pharmacotherapy. 2014;34:758-763. doi:10.1002/phar.1435

LaVie

Anderson

O’Neal

Jr Rice

Saavedra

O’Neal

CS.

Neutropenia associated with long-term ceftaroline use. Antimicrob Agents Chemother. 2016;60:264-269. doi:10.1128/AAC.01471-15

Teflaro® [package insert]. Madison, NJ: Allergan; 2018.